Patents Assigned to Semorex Technologies Ltd.
  • Treatment of proliferative disorders with a chemiluminescent agent
    Patent number: 10092565
    Abstract: Methods employing chemiluminescent agents as therapeutically active agents in the treatment of proliferative disorders are disclosed. The chemiluminescent agents are used in the disclosed method without a therapeutically effective amount of a photosensitizer. Novel chemiluminescent agents having the general formula: are also disclosed, wherein X, Y, Z, R3 and R5-R9 are as defined herein.
    Type: Grant
    Filed: September 29, 2016
    Date of Patent: October 9, 2018
    Assignees: Semorex Technologies Ltd., Ariel-University Research and Development Company Ltd.
    Inventors: Bernard S. Green, Galia Luboshits, Michael A. Firer
  • TREATMENT OF PROLIFERATIVE DISORDERS WITH A CHEMILUMINESCENT AGENT
    Publication number: 20170014410
    Abstract: Methods employing chemiluminescent agents as therapeutically active agents in the treatment of proliferative disorders are disclosed. The chemiluminescent agents are used in the disclosed method without a therapeutically effective amount of a photosensitizer. Novel chemiluminescent agents having the general formula: are also disclosed, wherein X, Y, Z, R3 and R5-R9 are as defined herein.
    Type: Application
    Filed: September 29, 2016
    Publication date: January 19, 2017
    Applicants: Semorex Technologies Ltd., Ariel-University Research and Development Company Ltd.
    Inventors: Bernard S. GREEN, Galia LUBOSHITS, Michael A. FIRER
  • Treatment of proliferative disorders with a chemiluminescent agent
    Patent number: 9464079
    Abstract: Methods employing chemiluminescent agents as therapeutically active agents in the treatment of proliferative disorders are disclosed. The chemiluminiscent agents are used in the disclosed method without a therapeutically effective amount of a photosensitizer. Novel chemiluminescent agents having the general formula: are also disclosed, wherein X, Y, Z, R3 and R5-R9 are as defined herein.
    Type: Grant
    Filed: March 22, 2012
    Date of Patent: October 11, 2016
    Assignees: Semorex Technologies Ltd., Ariel-University Research and Development Company Ltd.
    Inventors: Bernard S. Green, Galia Luboshits, Michael A. Firer
  • TREATMENT OF PROLIFERATIVE DISORDERS WITH A CHEMILUMINESCENT AGENT
    Publication number: 20140010867
    Abstract: Methods employing chemiluminescent agents as therapeutically active agents in the treatment of proliferative disorders are disclosed. The chemiluminiscent agents are used in the disclosed method without a therapeutically effective amount of a photosensitizer. Novel chemiluminescent agents having the general formula: are also disclosed, wherein X, Y, Z, R3 and R5-R9 are as defined herein.
    Type: Application
    Filed: March 22, 2012
    Publication date: January 9, 2014
    Applicants: Ariel-University Research and Development Company Ltd., Semorex Technologies Ltd.
    Inventors: Bernard S. Green, Galia Luboshits, Michael A. Firer